Published in J Biol Chem on March 03, 1995
A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system. Genes Dev (1998) 2.63
Activation and repression by nuclear hormone receptors: hormone modulates an equilibrium between active and repressive states. Mol Cell Biol (1996) 1.32
Promoter-specific shifts in transcription initiation conferred by yeast TFIIB mutations are determined by the sequence in the immediate vicinity of the start sites. Mol Cell Biol (2001) 1.27
Apoptosis in coxsackievirus B3-caused diseases: interaction between the capsid protein VP2 and the proapoptotic protein siva. J Virol (2000) 1.25
Mutational analysis of the D1/E1 core helices and the conserved N-terminal region of yeast transcription factor IIB (TFIIB): identification of an N-terminal mutant that stabilizes TATA-binding protein-TFIIB-DNA complexes. Mol Cell Biol (1997) 1.24
TFIIB-directed transcriptional activation by the orphan nuclear receptor hepatocyte nuclear factor 4. Mol Cell Biol (1996) 1.20
Interactions between the retinoid X receptor and a conserved region of the TATA-binding protein mediate hormone-dependent transactivation. Proc Natl Acad Sci U S A (1995) 1.19
A nuclear hormone receptor-associated protein that inhibits transactivation by the thyroid hormone and retinoic acid receptors. Proc Natl Acad Sci U S A (1995) 1.16
The role of vitamin D receptor mutations in the development of alopecia. Mol Cell Endocrinol (2011) 1.15
Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3. Biochem J (1996) 1.11
Interferon regulatory factors and TFIIB cooperatively regulate interferon-responsive promoter activity in vivo and in vitro. Mol Cell Biol (1996) 1.07
Retinoid X receptor:vitamin D3 receptor heterodimers promote stable preinitiation complex formation and direct 1,25-dihydroxyvitamin D3-dependent cell-free transcription. Mol Cell Biol (1997) 1.05
Selective effects of ligands on vitamin D3 receptor- and retinoid X receptor-mediated gene activation in vivo. Mol Cell Biol (1996) 1.00
Human vitamin D receptor phosphorylation by casein kinase II at Ser-208 potentiates transcriptional activation. Proc Natl Acad Sci U S A (1996) 0.98
Repression of the luteinizing hormone receptor gene promoter by cross talk among EAR3/COUP-TFI, Sp1/Sp3, and TFIIB. Mol Cell Biol (2003) 0.97
Mutations in the vitamin D receptor and hereditary vitamin D-resistant rickets. Bonekey Rep (2014) 0.97
Role of hydrophobic amino acid clusters in the transactivation activity of the human glucocorticoid receptor. Mol Cell Biol (1997) 0.97
YY1 regulates vitamin D receptor/retinoid X receptor mediated transactivation of the vitamin D responsive osteocalcin gene. Proc Natl Acad Sci U S A (1997) 0.94
Human TAF(II)55 interacts with the vitamin D(3) and thyroid hormone receptors and with derivatives of the retinoid X receptor that have altered transactivation properties. Mol Cell Biol (1999) 0.91
Interaction of the 1alpha,25-dihydroxyvitamin D3 receptor at the distal promoter region of the bone-specific osteocalcin gene requires nucleosomal remodelling. Biochem J (2002) 0.91
TFIID (TBP) stabilizes the binding of MyoD to its DNA site at the promoter and MyoD facilitates the association of TFIIB with the preinitiation complex. Nucleic Acids Res (1998) 0.89
Transcriptional repression by Rev-erbA alpha is dependent on the signature motif and helix 5 in the ligand binding domain: silencing does not involve an interaction with N-CoR. Nucleic Acids Res (1996) 0.88
Vitamin D interferes with transactivation of the growth hormone gene by thyroid hormone and retinoic acid. Mol Cell Biol (1996) 0.84
Vitamin D resistance and colon cancer prevention. Carcinogenesis (2011) 0.83
Nuclear microenvironments support physiological control of gene expression. Chromosome Res (2003) 0.83
Allosteric interaction of the 1alpha,25-dihydroxyvitamin D3 receptor and the retinoid X receptor on DNA. Nucleic Acids Res (1997) 0.81
The coactivator dTAF(II)110/hTAF(II)135 is sufficient to recruit a polymerase complex and activate basal transcription mediated by CREB. Proc Natl Acad Sci U S A (2001) 0.80
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature (2000) 7.66
The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages. Proc Natl Acad Sci U S A (1998) 3.47
Mutually dependent secretion of proteins required for mycobacterial virulence. Proc Natl Acad Sci U S A (2005) 3.29
Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability. Antimicrob Agents Chemother (1999) 2.74
The biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis. Identification and functional analysis of CMAS-2. J Biol Chem (1995) 2.40
Transcription of the procyclic acidic repetitive protein genes of Trypanosoma brucei. Mol Cell Biol (1990) 2.31
Biochemical and genetic data suggest that InhA is not the primary target for activated isoniazid in Mycobacterium tuberculosis. J Infect Dis (1996) 2.13
Molecular characterization and inhibition of a Plasmodium falciparum aspartic hemoglobinase. EMBO J (1994) 2.00
Ras-stimulated extracellular signal-related kinase 1 and RhoA activities coordinate platelet-derived growth factor-induced G1 progression through the independent regulation of cyclin D1 and p27. J Biol Chem (1997) 1.47
Retinoid X receptors stimulate and 9-cis retinoic acid inhibits 1,25-dihydroxyvitamin D3-activated expression of the rat osteocalcin gene. Mol Cell Biol (1993) 1.36
Ternary complexes and cooperative interplay between NCoA-62/Ski-interacting protein and steroid receptor coactivators in vitamin D receptor-mediated transcription. J Biol Chem (2001) 1.27
Isolation and characterization of a novel coactivator protein, NCoA-62, involved in vitamin D-mediated transcription. J Biol Chem (1998) 1.10
Regulation of Saccharomyces cerevisiae flavohemoglobin gene expression. J Biol Chem (1995) 1.05
HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells. J Biol Chem (2000) 1.03
Vitamin D receptor and nuclear receptor coactivators: crucial interactions in vitamin D-mediated transcription. Steroids (2001) 0.96
Differential regulation and transcriptional control of immediate early gene expression in forskolin-treated WEHI7.2 thymoma cells. Mol Endocrinol (1998) 0.94
Rat cellular retinol-binding protein: cDNA sequence and rapid retinol-dependent accumulation of mRNA. Proc Natl Acad Sci U S A (1987) 0.88
Matrix metalloproteinase-13 influences ERK signalling in articular rabbit chondrocytes. Osteoarthritis Cartilage (2006) 0.88
The N-terminal domain of transcription factor IIB is required for direct interaction with the vitamin D receptor and participates in vitamin D-mediated transcription. Mol Endocrinol (1997) 0.85
Rapid and simple amplification of a specific RNA sequence by the polymerase chain reaction. Trends Genet (1989) 0.85
New insight into the structure and functions of the vitamin D receptor. Semin Nephrol (1994) 0.83
Novel gene structure and evolutionary context of Caenorhabditis elegans globin. Gene (1993) 0.83
How do retinoids work? Dermatologica (1987) 0.82
The psychometric and cardiac effects of dimenhydrinate in the hyperbaric environment. Pharmacotherapy (2000) 0.81
Using transfection to study gene expression in trypanosomes. Biochem Soc Trans (1990) 0.81
Involvement of thyrotroph embryonic factor in calcium-mediated regulation of gene expression. J Biol Chem (2000) 0.80
Functional analysis of the mouse ICER (Inducible cAMP Early Repressor) promoter: evidence for a protein that blocks calcium responsiveness of the CAREs (cAMP autoregulatory elements). Mol Endocrinol (1999) 0.79
The autonomous transactivation domain in helix H3 of the vitamin D receptor is required for transactivation and coactivator interaction. J Biol Chem (1999) 0.79
Elevated glutathione S-transferase gene expression is an early event during steroid-induced lymphocyte apoptosis. J Cell Physiol (1993) 0.77
The psychometric and cardiac effects of pseudoephedrine in the hyperbaric environment. Pharmacotherapy (2000) 0.76